Caligan Partners
NBP icon

Caligan Partners’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Caligan Partners’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,499,330
Closed -$4.34M – 15
2024
Q3 		$4.34M Buy
3,499,330
+124,539
+4% +$156K 1.38% 10
2024
Q2 		$5.64M Buy
3,374,791
+2,618,253
+346% +$4.68M 1.32% 12
2024
Q1 		$1.41M Buy
+756,538
New +$1.39M 0.37% 12

Other funds holding NBP

HHLR Advisors
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EDBI Pte Ltd
EDBI Pte Ltd Singapore $94.4M AUM 32.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Cantor Fitzgerald
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Caligan Partners's NBP Position: Q4 2024 in Review

Caligan Partners sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2024, closing a stake of 3,499,330 shares — an estimated $4.34M sold.

Caligan Partners first reported a position in NBP in Q1 2024 and held it in 3 quarters. The position peaked at $5.64M in Q2 2024. 28 funds tracked by Wall St. Rank hold NBP as of Q4 2024.

  • Caligan Partners reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2024 after selling out during the quarter.
  • Caligan Partners sold 3,499,330 NovaBridge Biosciences American Depositary Shares shares in Q4 2024, an estimated $4.34M.
  • Caligan Partners first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2024 and held it in 3 quarters.
  • Caligan Partners's NovaBridge Biosciences American Depositary Shares position peaked at $5.64M in Q2 2024.
  • 28 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2024.

Based on Caligan Partners's 13F filing for Q4 2024, filed 14 Feb 2025.